parkinson's disease triple agonist glp-1 gip glucagon clinical trial Targeting GLP-1, & GCG in Obesity and Type 2 Diabetes Research Targeting Metabolic Dysfunction in Parkinson's
Description
no major safety concerns were observed
Ozempic, Wegovy, Zepbound, and Mounjaro are GLP-1 medications that help lower blood sugar
Leah Joseph at Josephcarerx Clarifies the Key Differences Between GLP-1 and Ozempic to Help You Make Informed Health Decisions.
Expert Guidance Available in Coral Gables and Pinecrest, FL.
Some sub-analyses of large clinical trials suggest that GLP-1RA and sodium-glucose cotransporter 2 inhibitor combination therapy may provide more significant reductions in heart failure hospitalization and renal composite events than each alone
A comprehensive phase 3 program is ongoing to evaluate efficacy, safety, and cardiovascular/renal outcomes in people with obesity and/or T2D
